Lynch syndrome and Muir-Torre phenotype associated with a recurrent variant in the 3’UTR of the MSH6 gene
Giulia Cini(National Cancer Institute), Maria Grazia Tibiletti(University of Insubria), Roberta Maestro(Centro di Riferimento Oncologico), Anastasia Dell’Elice(University of Chieti-Pescara), Elisa Pin(KTH Royal Institute of Technology), Ilaria Bestetti(IRCCS Istituto Auxologico Italiano), Slobodanka Radović(Istituto di Genomica Applicata), Nora Sahnane(University of Insubria), Anna Maria Chiaravalli(Ospedale di Circolo e Fondazione Macchi), Ileana Carnevali(University of Insubria), Alessandra Viel(Centro di Riferimento Oncologico), Franco Armelao(Ospedale Santa Chiara)
Cited by 6
Related Papers
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
|Genetics in Medicine|2019|666
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
twist is a potential oncogene that inhibits apoptosis
|Genes & Development|1999|508
Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers
|Oncotarget|2016|309